BQ-GPEP-A2G2S2-10U Certificate of Analysis Cat. #: BQ-GPEP-A2G2S2-10U Batch: B318-03 Size: 10 μg (3.49nmol) Glycan Structure Oxford Notation CFG Notation Text Notation The glycopeptide is comprised of an A2G2S2 glycan attached to the asparagine amino acid of a peptide with the sequence Lysine-Valine-Alanine-Asparagine-Lysine-Threonine (KVANKT). Glycopeptide Purity > 90% as determined by UHPLC Monoisotopic mass: 2865.1763 [M+H]+ Storage conditions: -20 C BQ-GPEP-A2G2S2-10U Quantity Summary The amount of GPEP-A2G2S2 glycopeptide to be dispensed per vial is determined by quantitative Nuclear Magnetic Resonance (qnmr) of the bulk glycopeptide stock. Once dispensed the amount of glycopeptide per vial is determined by monosaccharide analysis and sialic acid analysis. These determinations are detailed on the following pages, but a summary is provided below: Amount of BQ-GPEP-A2G2S2-10U per vial qnmr based determination: derived from glycopeptide bulk stock = 10.00 ± 0.26 µg (3.49 nmol) Monosaccharide based determination (GlcN HCl hydrolysis) = 10.71 ± 0.36µg (3.74 nmol) Sialic acid based determination = 9.97 ± 0.54µg (3.48nmol)
Quantitative Nuclear Magnetic Resonance (qnmr) 3.0E+08 2.8E+08 2.6E+08 2.4E+08 2.2E+08 2.0E+08 1.8E+08 1.6E+08 1.4E+08 1.2E+08 1.0E+08 8.0E+07 6.0E+07 4.0E+07 2.0E+07 0.0E+00.0 5.5 5.0 4.5 4.0 3.5 3.0 f1 (ppm) 2.5 2.0 1.5 1.0 0.5 0.0 Figure 1. 1 H-NMR (500 MHz) of BQ-GPEP-A2G2S2-Bulk in D 2 O (Batch Number: B318-03) Sample Concentration (mm) calculated using a certified quantitative standard. BQ-GPEP-A2G2S2-Bulk 0.4742 ± 0.0023 Table 1. Concentration of BQ-GPEP-A2G2S2-Bulk calculated by qnmr The concentration of the BQ-GPEP-A2G2S2 stock was calculated by qnmr by comparison to a certified quantitative standard (Table 1). This value was used to determine the amount of sample to be dispensed to obtain 10 µg of glycopeptide per vial.
Monosaccharide analysis of BQ-GPEP-A2G2S2-10U Quantitative monosaccharide analysis using the Ludger LT-MONO-96 kit was performed on 3 replicates of BQ-GPEP-A2G2S2 using 6M hydrochloric acid hydrolysis (HCl) to release the N-acetylglucosamine (GlcNAc hydrolysed to GlcN) constituents of the glycopeptide. The GlcN monosaccharides were labelled with 2- aminobenzoic acid and chromatography was performed on a UHPLC equipped with a LudgerSep ur2 monosaccharide analysis column (LS-UR2-2.1x50). Figure 2. LudgerSep-uR2 HPLC profile of 2-aminobenzoic acid (2-AA) labeled monosaccharides of HCl hydrolysed BQ-GPEP-A2G2S2-10U (Batch B318-03). The ManN monosaccharide is due to epimerisation of the GlcN monosaccharide during sample processing. Quantity of GlcN per vial = 14.96 ± 0.5 nmol Quantity of BQ-GPEP-A2G2S2-10U per vial (determined by GlcN content) = 10.71 ± 0.36µg (3.74 nmol)
Sialic acid analysis of BQ-GPEP-A2G2S2-10U Quantitative sialic acid analysis was performed on 3 separate vials of BQ-GPEP-A2G2S2-10U using the LudgerTag DMB sialic acid labelling kit (LT-KDMB-A1). The labelled sialic acid chromatography was performed on a UHPLC equipped with a LudgerSep ur2 column (LS-UR2-2.1x100). Figure 3. LudgerSep-uR2 HPLC profile of 1,2-diamino-4,5-methylenedioxybenzene.2HCl (DMB) labelled Neu5Ac of acetic acid hydrolysed BQ-GPEP-A2G2S2-10U (Batch B318-03). Quantity of NeuAc determinated per vial = 6.96 ± 0.38 nmol Quantity of BQ-GPEP-A2G2S2-10U per vial (determined by NeuAc content) = 9.97 ± 0.54µg (3.48 nmol)
Glycopeptide Purity and Identity of BQ-GPEP-A2G2S2-10U 80,000,000 counts V-tag-GPEP-A2G2S2-B318-03-rep-2 Emission_1 60,000,000 22.41 40,000,000 20,000,000 19.41 21.69 22.96 26.14-10,000,000 min 10.0 15.0 20.0 25.0 30.0 35.0 Figure 4. HILIC UHPLC profile of V-Tag (Ludger fluorophore tag) labelled BQ-GPEP-A2G2S2-10U (Batch B318-03). Sample purity determined as >90% by HILIC chromatography of fluorescence tagged glycopeptide. Data: GPEP-A2G2S2-B318-03-2000-pos-0001.M3[c] 25 Jan 2013 12:23 Cal: RD-B31O-01-pos-850-24 Jan 2013 9:11 Shimadzu Biotech Axima Resonance 2.9.0.20090423: Mode positive, High 2000+, Power: 100 %Int. 100 90 80 70 45 mv[sum= 4137 mv] Profiles 1-92 Unsmoothed 2283.9 GPEP-A2G2 (M + H) 60 50 40 30 20 10 0 GPEP-A2G2 (M + Na) 2305.8 GPEP-A2G2S1 2575.2 (M + H) 2100 2200 2300 2400 2500 2600 2700 2800 m/z 1[c] Figure 5. Positive ion MALDI mass spectrum of BQ-GPEP-A2G2S2-10U (Batch B318-03). MALDI mass spectrometry analysis identified the non-sialylated form of the glycopeptide. Sialic acids are not stable in this type of mass spectrometry technique, although a small amount of monosialylated glycopeptide was identified (mass 2575 Da). Protonated, sodiated and potassiated adducts of the glycopeptide were observed.